Simplify Your Downstream Calculations With Bioprocessing Downstream Calculators

Reimagine Sustainability In Bioprocessing

Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective

Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

Rapid Process Development And Technical Support For AAV Scaleup

mAb Up- And Downstream Process Intensification Strategies

The Role Of Peptones In Boosting Quality And Yield

2025 CGT Regulatory Outlook

Unlocking The Future Of Allogeneic Cell Therapy For Oncology

2024 Regulatory Outlook With FDA's Drs. Peter Marks And Nicole Verdun

mRNA For Cancer Immunotherapy: 2024 Outlook

Stability To Scalability: The Future Of Viral Vector Therapies

Driving Down COGS: Automation's Role In Cell Therapy Manufacturing

Tackling Cell And Gene Therapies' Top 3 Regulatory Impediments

2025 CGT Regulatory Outlook | Audience Q&A

Navigating Global Regulations, Equity Challenges, And The Future Of Patient Access

How The FDA's 2024 Draft Guidances Will Influence CGT Regulation In 2025

How The New Administration Could Shape FDA Oversight, Compliance, And Guidance In 2025

How The FDA Strengthens Industry Collaboration

Key Regulatory Challenges, Innovations, And Opportunities For CGT In 2025

Congruence And Divergence In Global Regulatory Approvals

Unlocking The Future Of Allogeneic Cell Therapy For Oncology | Audience Q&A

Autoimmune Disease Research's Impact On The Development Of Cell Therapies For Oncology

Defining The CMC / Clinical Relationship For Allogeneic Cell Therapies

Improvements In Scaling And Sequencing For Allogeneic Cell Therapies For Oncology

Best Practices For Effective Donor Management

Rapid Process Development And Technical Support For AAV Scaleup

Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials

mAb Up- And Downstream Process Intensification Strategies

Mitigate Bioprocessing Limitations With A More Efficient And Sustainable Harvest Solution

Accelerate Process Development With HTS Chromatography Tools

Accelerating mAb Process Development In The Growing Therapeutics Market

The Way Forward: Supply Chain Solutions

Scalable By Design: Streamlining Cell Culture Media Manufacturing

Analytical Solutions To Help Accelerate Bioprocessing Success

Innovative Contamination Control: Enabling Integrity And Efficiency

Planning for Success: Supply Resiliency Strategies for Bench to Production

Scalable Production Of Lentivirus For Research To Commercial Manufacturing

Dr. Peter Marks Talks a Standardized Playbook for Gene Therapy Manufacturing

Race To The Regulatory Finish Line: Dr. Nicole Verdun Talks Efficiencies In Platform Technologies

Improvements In Scaling And Sequencing For Allogeneic Cell Therapies For Oncology

mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A

Achieving Stability For mRNA

Rapid Process Development And Technical Support For AAV Scaleup

Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials

Process Liquids And Buffers Offering

Auto, Allo, And AI

Unlocking The Future Of Allogeneic Cell Therapy For Oncology | Audience Q&A

Accelerate Process Development With HTS Chromatography Tools

Genentech, Myeloid's Approaches To mRNA Technologies

Dr. Peter Marks Talks a Standardized Playbook for Gene Therapy Manufacturing

Race To The Regulatory Finish Line: Dr. Nicole Verdun Talks Efficiencies In Platform Technologies

mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A

Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials

Challenge #2: Rare Or Ultra-Rare Study Design Considerations And Use Of Existing Data

How The FDA's 2024 Draft Guidances Will Influence CGT Regulation In 2025

How The New Administration Could Shape FDA Oversight, Compliance, And Guidance In 2025

Understanding AI And Machine Learning's Impact On CGT with Dr. Peter Marks and Dr. Nicole Verdun

Key Regulatory Challenges, Innovations, And Opportunities For CGT In 2025

2024 Regulatory Outlook With Dr. Peter Marks And Dr. Nicole Verdun | Audience Q&A

Challenge #1: The Changing Regulatory Landscape

Congruence And Divergence In Global Regulatory Approvals

Improvements In Scaling And Sequencing For Allogeneic Cell Therapies For Oncology

mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A

Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials

Process Liquids And Buffers Offering

Auto, Allo, And AI

The Way Forward: Supply Chain Solutions

Thermo Fisher Scientific Bio-Expo Live 2024: Downstream Bioprocessing

An Active Release Mechanism For Magnetic Separation And Cell Isolation

Supply Chain And Operational Challenges Facing mRNA

Quality Control Assays

Driving Down COGS Audience Q&A

Planning for Success: Supply Resiliency Strategies for Bench to Production

Rapid Process Development And Technical Support For AAV Scaleup

Quality Control Assays

Analytical Solutions To Help Accelerate Bioprocessing Success

Innovative Contamination Control: Enabling Integrity And Efficiency

Regulatory Compliance And Viral Vectors

Market Demand For AAV Vectors

Overcoming Capacity Constraints

Scaling Viral Vectors

Manufacturing Hurdles With Viral Vectors

Rapid Process Development And Technical Support For AAV Scaleup

Auto, Allo, And AI

The Way Forward: Supply Chain Solutions

An Active Release Mechanism For Magnetic Separation And Cell Isolation

Scalable By Design: Streamlining Cell Culture Media Manufacturing

Analytical Solutions To Help Accelerate Bioprocessing Success

Driving Down COGS Audience Q&A

Innovative Contamination Control: Enabling Integrity And Efficiency

Planning for Success: Supply Resiliency Strategies for Bench to Production

Scalable Production Of Lentivirus For Research To Commercial Manufacturing

Pipeline Progress

Mitigating Risk In Process Automation